According to FutureWise analysis the market for single-use bioprocessing in 2023 was US$ 11.95 billion, and is expected to reach US$ 53.9 billion by 2031 at a CAGR of 20.70%.
Single-use bioprocessing, also called disposables, refers to pharmaceutical products and solutions made to be used once and then discarded. Among the most commonly used single-use bioprocessing products are media bags, containers, filtration assemblies, disposable bioreactors, disposable mixers, tubes, connectors, and samplers. In addition to monoclonal antibodies and vaccines, these products are commonly used in the cultivation of plant cells and in the production of cell therapies. The devices are also used by biopharmaceutical companies and life science research organizations in order to increase productivity and to reduce cross-contamination risk.
For the research and manufacturing of pharmaceutical goods customised medicine, and others, single-use bioprocessing uses disposable technologies. During the development of medications and the manufacturing of various biopharmaceuticals, the use of single-use bioprocessing products has increased significantly. This invention has changed both the upstream and downstream processes of medication manufacture, making them faster, easier, and less expensive. Single-use bioprocessing systems are biopharmaceutical production (bioprocessing) systems. Plastic components that have been sterilised and sealed by gamma irradiation are frequently used in single-use bioprocessing systems. Furthermore, because of the advantages, government regulatory agencies are increasingly using single-use bioprocessing systems. The Therapeutic Goods Administration (TGA) of Australia, for example, permits the use of single-use bioprocessing systems in buffer preparation, mixing, and other upstream processes. Aside from that, TGA recommended GMP regulations for filters and other single-use bioprocessing equipment. Because of the increased need for biologics, the global Single-Use Bioprocessing Market is expected to rise. During the development stages of medications and the manufacturing of various biopharmaceuticals, the use of Single-Use Bioprocessing Market goods has increased significantly. The surge in demand for biopharmaceuticals, the rise in acceptance of disposable technologies, the minimal risk of product cross-contamination attributable to SUB technologies, and the need for less floor space are all factors driving the expansion of the single-use bioprocessing market. However, challenges like extractability and leachability, as well as strict restrictions governing the use of disposable systems in the biopharmaceutical industry, are impeding the market's growth. Furthermore, monoclonal antibodies (mAb) are produced using single-use bioprocessing methods, hence this sector dominates the worldwide single-use bioprocessing market.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Single-use-Bioprocessing/10062
Single-use Bioprocessing Market Segmentation:
By Product
- Media Bags and Containers
- Filtration Assemblies
- Single-use Bioreactors
- Disposable Mixers
- Others
By End User
- Academic and Clinical Research Institutes
- Biopharmaceutical Manufacturers
By Application
- Filtration
- Chromatography
- Membrane Filtration
- Refining and Separation
- Storage
- Cell Culture
- Purification
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Single-use Bioprocessing Market:
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Sartorius Stedim Biotech S.A.
- Merck Millipore
- Danaher Corporation
- 3M Company
- Eppendorf AG
- Hamilton Company
- Corning Incorporated
- Cesco Bioengineering Co. Ltd.
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=10062%20type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Single-use Bioprocessing Market By Product, By End User, By Application and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
